HER2 Support Group Forums - First-in-class antibody-drug conjugate shows significant clinical benefit against met

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- Breast Cancer Newsfeed (https://her2support.org/vbulletin/forumdisplay.php?f=52)

- - First-in-class antibody-drug conjugate shows significant clinical benefit against met (https://her2support.org/vbulletin/showthread.php?t=64082)

News	11-08-2015 10:14 AM

First-in-class antibody-drug conjugate shows significant clinical benefit against met

IMMU-132, an anti-Trop-2 antibody-drug conjugate (ADC) was safe, tolerable,and yielded meaningful clinical activity in heavily pretreated patients with metastatic triplenegativebreast cancer...

More...

All times are GMT -7. The time now is 08:31 PM.